Diaceutics Shows Missed Opportunities for Pharma and Patients
Diaceutics, a medtech company enabling patient testing globally, announced research results that show over 156,000 cancer patients in the U.S. and Europe could be missing out on targeted life-saving drugs because of suboptimal diagnostic testing. It also found that substandard testing practices cause pharma companies in the U.S. and Europe to possibly miss out on up to $16.6 billion in potential revenue each year.
Diaceutics’ research also found that even four years after new diagnostic tests become available, just 50% of patients that may be eligible for precision drugs will have been tested by their physician.
About 1.7 million cancer patients in the U.S. and Europe undergo tests each year to determine if there are precision drugs available that are likely to work well with their genetic makeup more so than more commonly prescribed drugs. Suboptimal testing practices such as delayed reporting of test results, false negatives, and sample management issues, could affect potential opportunities for patients and pharma companies.
Social Media's Influence on Young Women's Reproductive Decisions
February 20th 2025In this Q&A, Organon's Chief Communications Officer, Becky Edwards discusses how much social media and influencers sway decisions about birth control methods, potential consequences of these misinformed choices, and more.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
